How many people with diabetic peripheral neuropathy have cardiac autonomic neuropathy?
Not Applicable
- Conditions
- Health Condition 1: E00-E89- Endocrine, nutritional and metabolic diseases
- Registration Number
- CTRI/2019/10/021742
- Lead Sponsor
- KASTURBA MEDICAL COLLEGE
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Diabetic peripheral neuropathy(with h/o diabetes and symptoms and/or signs of diabetic peripheral neuropathy), NCV
Exclusion Criteria
Patients taking beta blockers, clonidine, prazosin, steroids, ohenytoin, cisplatin, vincristine, amiodarone, fluoroquinolones, metronidazole, isoniazid, nitrofurantoin
chronic kidney disease
h/o significant alcohol intake
vitamin b12 deficiency
HIV
Severe systemic disease(cardiac, pulmonary, malignancy)
Unstable patient(A/E COPD, Bronchial asthma, severe HTN, ECG s/o myocardial ischemia or infarct)
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Prevalence of autonomic neuropathy in patients who have diabetic peripheral neuropathyTimepoint: 3 years
- Secondary Outcome Measures
Name Time Method Autonomic dysfunction stages correlation with various types of diabetic peripheral neuropathy and their severity <br/ ><br>Autonomic dysfunction correlation with hypoglycemia and neuroglycopeniaTimepoint: 2 years